Advanced gastroprotective formulation that provides effective relief from acid-related disorders while promoting digestive comfort.
Key Indications:
Composition:
Rabeprazole Sodium (GR) 20 mg + Domperidone (SR) 30 mg
Product Overview:
REHAPPI-D Capsules is a specialized gastroprotective formulation that combines Rabeprazole Sodium and Domperidone to support the effective management of acid-related gastrointestinal disorders. The formulation helps reduce gastric acid secretion, relieve symptoms associated with acid reflux, and improve digestive comfort while providing support for nausea and vomiting related to gastrointestinal conditions.
Manufactured through trusted quality-focused partners, REHAPPI-D Capsules reflects SYNKORA GLOBAL EXPORTS’ commitment to delivering reliable pharmaceutical solutions for healthcare distributors, importers, hospitals, and healthcare providers across international markets.
Key Benefits:
